Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$23.88 – $35.83
9% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $642.83B | $695.62B | $645.94B | $756.23B | $744.40B | $741.75B | $789.40B | $830.57B |
| Cost of revenue | $196.40B | $185.27B | $161.31B | $174.83B | $200.93B | $155.33B | $168.81B | $192.43B |
| Gross profit | $446.44B | $510.35B | $484.63B | $581.39B | $543.48B | $586.42B | $620.59B | $638.15B |
| Gross margin | 69.4% | 73.4% | 75.0% | 76.9% | 73.0% | 79.1% | 78.6% | 76.8% |
| R&D | $127.63B | $125.49B | $138.82B | $158.03B | $156.69B | $169.02B | $171.63B | $159.66B |
| Operating income | $86.15B | $125.50B | $56.55B | $53.75B | $40.04B | $53.41B | $54.38B | $40.46B |
| EBITDA | $117.85B | $163.22B | $89.42B | $94.55B | $87.26B | $103.61B | $104.49B | $90.46B |
| Net income | $63.39B | $121.77B | $41.94B | $47.95B | $55.43B | $42.41B | $46.43B | $38.80B |
| Net margin | 9.9% | 17.5% | 6.5% | 6.3% | 7.4% | 5.7% | 5.9% | 4.7% |
| EPS (diluted) | 221.12 | 424.80 | 146.90 | 167.25 | 193.30 | 147.86 | 163.76 | 137.41 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $896.0B | $198.15 | $188.10–$209.35 | 2 |
| 2028 | $946.4B | $233.69 | $221.84–$246.90 | 3 |
| 2029 | $965.3B | $234.84 | $222.93–$248.12 | 4 |
| 2030 | $997.7B | $283.66 | $269.28–$299.70 | 2 |
Forward consensus · source: Financial Modeling Prep
EISAI CO LTD
No one on the platform currently holds ESALF.
No tracked institution reports a position in ESALF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $80.0000 | |
| 2026-09-30 | $80.0000 | |
| 2026-03-31 | $80.0000 | 2026-06-01 |
| 2025-09-30 | $80.0000 | 2025-11-18 |
| 2025-03-31 | $80.0000 | 2025-05-30 |
| 2024-09-30 | $80.0000 | 2024-11-19 |
| 2024-03-28 | $80.0000 | 2024-05-29 |
| 2023-09-29 | $80.0000 | 2023-11-17 |
No one on the platform has traded ESALF yet.
| $7.6B |
| — |
| NOBDFNorth Bud Farms Inc. | $0.00 | +0.00% | $634 | — |
| SFOSFShanghai Fosun Pharmaceutical (Group) Co., Ltd. | $2.02 | +0.00% | $5.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.2× earnings vs its 0.3× historical median P/E.
Fair value ≈ $42.77 · price $25.00 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.